The number of hospital discharges for malignant neoplasm of the prostate in Sweden showed a fluctuating pattern from 2013 to 2023. In 2023, the figure stood at 5.17 thousand, indicating a marginal year-on-year decrease of 2.43% compared to 2022. Over the past five years, the compound annual growth rate (CAGR) has been -2.82%, highlighting a consistent downward trend. Particularly noteworthy are the significant drops in 2016 (-10.35%) and 2020 (-14.16%).
Looking ahead, the forecasted data suggest a continued decline, with a 5-year CAGR projected at -4.84%, and an overall decrease of approximately 21.96% from 2023 to 2028. By 2028, the number of hospital discharges is expected to fall to 3.82 thousand.
Future trends to watch for include advancements in prostate cancer treatments and early detection methods, which could further reduce hospital discharge rates. Additionally, changes in healthcare policies and demographic shifts in the aging population may also impact these trends.
